CD81 is an entry coreceptor for hepatitis C virus

被引:227
作者
Cormier, EG
Tsamis, F
Kajumo, F
Durso, RJ
Gardner, JP
Dragic, T
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Progen Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
D O I
10.1073/pnas.0402253101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hepatitis C virus (HCV) envelope glycoproteins E1/E2 can pseudotype retroviral particles and efficiently mediate entry into target cells. Using this experimental system, we determined HCV tropism for different cell types. Only primary hepatocytes and one hepatoma cell line were susceptible to HCV pseudovirus entry, which could be inhibited by sera from HCV-infected individuals. Furthermore, expression of the putative HCV receptor CD81 on nonpermissive human hepatic but not murine cells enabled HCV pseudovirus entry. Importantly, inhibition of viral entry by an anti-CD81 mAb occurred at a step following HCV attachment to target cells. Our results indicate that CD81 functions as a post-attachment entry coreceptor and that other cellular factors act in concert with CD81 to mediate HCV binding and entry into hepatocytes.
引用
收藏
页码:7270 / 7274
页数:5
相关论文
共 38 条
[1]   Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets [J].
Afonso, AMR ;
Jiang, JJ ;
Penin, F ;
Tareau, C ;
Samuel, D ;
Petit, MA ;
Bismuth, H ;
Dussaix, E ;
Féray, C .
JOURNAL OF VIROLOGY, 1999, 73 (11) :9213-9221
[2]   Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor [J].
Bartosch, B ;
Vitelli, A ;
Granier, C ;
Goujon, C ;
Dubuisson, J ;
Pascale, S ;
Scarselli, E ;
Cortese, R ;
Nicosia, A ;
Cosset, FL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) :41624-41630
[3]   Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes [J].
Bartosch, B ;
Dubuisson, J ;
Cosset, FL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :633-642
[4]   Quantitative analysis of hepatitis C virus in peripheral blood and liver: Replication detected only in liver [J].
Boisvert, J ;
He, XS ;
Cheung, R ;
Keeffe, EB ;
Wright, T ;
Greenberg, HB .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (07) :827-835
[5]   Detection of virus-like particles in liver biopsies from HCV-infected patients [J].
Bosman, C ;
Valli, MB ;
Bertolini, L ;
Serafino, A ;
Boldrini, R ;
Marcellini, M ;
Carloni, G .
RESEARCH IN VIROLOGY, 1998, 149 (05) :311-314
[6]   Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver [J].
Cabot, B ;
Martell, M ;
Esteban, JI ;
Sauleda, S ;
Otero, T ;
Esteban, R ;
Guàrdia, J ;
Gómez, J .
JOURNAL OF VIROLOGY, 2000, 74 (02) :805-811
[7]   Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro [J].
Castet, V ;
Fournier, C ;
Soulier, A ;
Brillet, R ;
Coste, J ;
Larrey, D ;
Dhumeaux, D ;
Maurel, P ;
Pawlotsky, JM .
JOURNAL OF VIROLOGY, 2002, 76 (16) :8189-8199
[8]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[9]   Analysis of a successful immune response against hepatitis C virus [J].
Cooper, S ;
Erickson, AL ;
Adams, EJ ;
Kansopon, J ;
Weiner, AJ ;
Chien, DY ;
Houghton, M ;
Parham, P ;
Walker, CM .
IMMUNITY, 1999, 10 (04) :439-449
[10]   Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies [J].
De Vos, R ;
Verslype, C ;
Depla, E ;
Fevery, J ;
Van Damme, B ;
Desmet, V ;
Roskams, T .
JOURNAL OF HEPATOLOGY, 2002, 37 (03) :370-379